Metformin hydrochloride for pre-eclampsia

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 11 Jun 2024: Trial registered, NCT06452498
  2. 19 Sep 2025: Trial started, NCT06452498

The trials

NCT06452498: Preeclampsia Intervention Netherlands

State
Under way
Phase
Phase 3
People
180 planned
Started
19 Sep 2025
Primary completion
19 Mar 2029
Arms
Metformin
Results
None posted
  1. 11 Jun 2024: Trial registered
  2. 19 Sep 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Apophage, Benofomin, Diabefagos, Diabex, Extended Release Metformin Hydrochloride, Fortamet, Glucaminol, Glucophage, Glucophage xr, Glucovance component metformin hydrochloride, Glumetza, Invokamet component metformin hydrochloride, Janumet component metformin hydrochloride, Kazano component metformin hydrochloride, Metformin XR, Metformin hydrochloride (HCl) 500mg tablet, Neodipa, Qternmet component metformin hydrochloride, Qternmet xr component metformin hydrochloride, Riomet, Riomet er, Segluromet component metformin hydrochloride, Siamformet, Trijardy xr component metformin hydrochloride, Walaphage, Xigduo component metformin hydrochloride, Zituvimet component metformin hydrochloride.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.